I Ask This Of You!
I have Parkinson's diseases and thought it would be nice to have a place where the contents of updated news is found in one place. That is why I began this blog.
I copy news articles pertaining to research, news and information for Parkinson's disease, Dementia, the Brain, Depression and Parkinson's with Dystonia. I also post about Fundraising for Parkinson's disease and events. I try to be up-to-date as possible.
I am not responsible for it's contents. I am just a copier of information searched on the computer. Please understand the copies are just that, copies and at times, I am unable to enlarge the wording or keep it uniformed as I wish.
This is for you to read and to always keep an open mind.
Please discuss this with your doctor, should you have any questions, or concerns.
Never do anything without talking to your doctor. I do not make any money from this website. I volunteer my time to help all of us to be informed. I will not accept any information about Herbal treatments curing Parkinson's, dementia and etc. It will go into Spam.
This is a free site for all with no advertisements.
Thank you for visiting!
Saturday, February 14, 2015
Wednesday, February 11, 2015
The diagnosis and estimation of disease severity in Parkinson's Disease was assessed using the APDM Mobility Lab. The APDM Mobility Lab uses wearable sensors and sophisticated signal processing to track even subtle changes in gait, stride, balance, rotation, and efficiency and range of movement in upper and lower limbs and torsos. Sensors are simply strapped on to the subject on various parts of the body, including the chest, waist, wrists and ankles. Subjects perform a standardised test and then a report is generated. For more information go to : http://apdm.com/gait-and-posture/Mobility-Lab/
Each person performed iTUG (instrumented Timed-Up- and-Go) and iSway (instrumented Sway) using the APDM Mobility Lab. They were assessed according to a range of Parkinson's Disease scores. iTUG and iSway variables differentiated people with Parkinson's Disease from people who did not. They correlated with all Parkinson's Disease severity measures. Objective scores correlated more strongly with iTUG than iSway.
The study identified sets of iTUG and iSway variables that correlate with Parkinson's Disease severity measures and differentiate people with Parkinson's Disease. The authors suggest that these gait and balance measures could therefore potentially serve as markers of Parkinson's Disease progression. They are consequently under evaluation for this purpose in the ongoing NIH Parkinson Disease Biomarker Program.
Reference : Journal of Neurological Science  345 (1-2) : 131-138 (D.C.Dewey, S. Miocinovic, I.Bernstein, P.Khemani, R.B.Dewey, R.Querry, S.Chitnis, R.B.Dewey Jr) Complete abstract : http://www.ncbi.nlm.nih.gov/pubmed/25082782
- One in 500 people in the UK has Parkinson's
- A combination of genetic changes and environmental factors may be responsible for the condition
- There are different sub-types of the disease and they share the symptoms of tremor, muscle rigidity and slowness of movements.
- Start QuoteA breath test would be really appealing because it's non-invasive, non-painful and can be done in seconds”Researcher Dr Simon Stotthttp://health.einnews.com/article/249260416/HMU80kgKXT3GZX_u
Tuesday, February 10, 2015
Amarantus Announces Publication in BRAIN of Eltoprazine Phase 2a Clinical Study for Treating Parkinson's Disease Levodopa-Induced Dyskinesia
- Eltoprazine demonstrated significant beneficial anti-dyskinesia effect at 5 and 7.5 mg doses, with no reduction of levodopa efficacy
- Eltoprazine was well tolerated at all dose levels, with no major adverse effects reported
- Results support advancing eltoprazine into Phase 2b chronic dosing, clinical studies, as a treatment for patients with Parkinson's disease levodopa-induced dyskinesia